Xcout IntelD&D Pharmatech competitors & alternatives
The 12 closest competitors and alternatives to D&D Pharmatech among biotechnology companies — ranked by similarity to what D&D Pharmatech actually does, not by market-cap band.
Subscribe to see D&D Pharmatech’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About D&D Pharmatech
D&D Pharmatech Inc. is a clinical-stage biotechnology company specializing in the development of GLP-1 receptor agonists and proprietary peptide technologies.
D&D Pharmatech at a glance
D&D Pharmatech is a biotechnology company headquartered in South Korea. Its most recent funding round raised $10.8M in June 2025. Xcout tracks 13 named people at D&D Pharmatech, including Seulki Lee (Chief Executive Officer).
D&D Pharmatech leadership
- Seulki LeeChief Executive Officer
- 홍성훈최고재무책임자 (CFO)
- Yen-Huei Lin최고기술 및 생산 책임자 (CTMO)
- 이슬기대표이사 (CEO) / 디앤디파마텍, Neuraly
- Martin G. Pomper창업자 및 前 CSO / Precision Molecular (現 Neuraly)
- Ted Dawson창업자 / Valted Seq
7 more named people on record for D&D Pharmatech, with roles, board committees and tenure — see the full roster →
D&D Pharmatech funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $10.8M | — | |
| — | $51M | 9 named | |
| — | $137.1M | 6 named | |
| — | $16.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 D&D Pharmatech competitors
Ranked by semantic similarity — how close each company is to D&D Pharmatech by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Parabolica Therapeutics develops proprietary peptide conjugation technologies focused on obesity and other metabolic conditions. The company researches and advances therapeutic programs through its scientific approach.
Similar biotechnology company
Adocia is a clinical-stage biotechnology company that develops innovative formulations of proteins, peptides, and metabolic hormones. The company specializes in creating treatments for diabetes and obesity, as well as immunoprotective scaffolds for cell therapies.
Similar biotechnology company
Inversago Pharma is a Canadian biotechnology company developing peripherally restricted CB1 receptor antagonists/inverse agonists for metabolic, fibrotic, and related diseases. Its drug-development programs are intended to serve patients with conditions such as obesity, metabolic syndrome, and diabetic kidney disease.
Similar biotechnology company
Imagine Pharma LLC is a biotechnology company that develops novel polypeptide-based platforms focused on oral delivery for biologic drugs, therapeutics for various disease states, and regenerative medicine. The company aims to create first-in-class treatments for conditions such as diabetes and wound healing, alongside offering oral peptide dietary supplements and functional ingredients for consumers.
Similar biotechnology company
Xianweida Biotech is a biopharmaceutical company focused on the research, development, and manufacturing of advanced weight management therapies and innovative treatments addressing urgent medical needs. The company is nearing commercialization and has partnered with Pfizer China for its GLP-1 drug portfolio.
Similar biotechnology company
Syntis Bio, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, dedicated to revolutionizing oral therapies for obesity and metabolic diseases.
Similar biotechnology company
Metabolic Solutions Development Company is a private biotechnology and drug discovery company founded in 2006. The firm focuses on investigating novel molecular targets and developing therapeutics to treat diabetes, metabolic syndrome, and related conditions.
Biotech
Guangzhou Innogen Pharmaceutical Group Co Ltd operates as a China-based investment holding firm with a core mission to research, develop, and bring to market medicinal products. The company specializes in producing innovative, human-compatible, and extended-duration GLP-1 receptor agonists, specifically targeting the treatment of diabetes and other metabolic conditions.
Similar biotechnology company
Protagonist Therapeutics is a clinical-stage biopharmaceutical company headquartered at the Pacific Research Center in Newark, California, focused on peptide drug discovery.
Similar biotechnology company
Meddenovo Drug Design is a Lyon, France-based biotechnology company operating at the intersection of AI and life sciences to build advanced computational technologies for peptide drug discovery.
Biotechnology & CRO
Gubra is a Danish biotech and contract research organization (CRO) specializing in preclinical peptide drug discovery, metabolic research, and advanced imaging services.
Biotech
Terrestrial Bio, Inc. develops the Tacterra microarray patch platform to deliver next-generation therapies, such as GLP-1, through the skin using dissolvable biomaterial tips. The technology eliminates the need for needles and refrigeration, enabling patients to self-administer treatments pain-free at home or on the go.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of D&D Pharmatech and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for D&D Pharmatechand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →